| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |